Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

BACKGROUND: Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Vitale, Maria Giuseppa, Scagliarini, Sarah, Galli, Luca, Pignata, Sandro, Lo Re, Giovanni, Berruti, Alfredo, Defferrari, Carlotta, Spada, Massimiliano, Masini, Cristina, Santini, Daniele, Ciuffreda, Libero, Ruggeri, Enzo Maria, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Giustini, Lucio, Hamzaj, Alketa, Procopio, Giuseppe, Caserta, Claudia, Sabbatini, Roberto
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://ncbi.nlm.nih.gov/pubmed/29979712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0199642
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg